This inventor holds 6 USPTO granted patents. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Gmbh. Active years: 1982-1992.
Company Filing History:
5 out of 278 
1 out of 306 
Years Active: 1982-1992
Title: Genus J Possanza: Innovator in Anti-Inflammatory Treatments
Introduction
Genus J Possanza is a notable inventor based in Ridgefield, CT (US). He has made significant contributions to the field of medicine, particularly in the development of anti-inflammatory treatments. With a total of 6 patents to his name, Possanza's work has the potential to impact patient care positively.
Latest Patents
Among his latest patents is a method for treating inflammation. This method involves administering a therapeutically effective amount of a specific compound designed to alleviate inflammation in patients. Another significant patent includes novel thienylbenzylamine compounds, which are also aimed at treating inflammation. These compounds are characterized by their unique chemical formulas, which are defined in the respective patents.
Career Highlights
Possanza has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH. His experience in these organizations has allowed him to develop and refine his innovative approaches to treating inflammation.
Collaborations
Throughout his career, Genus J Possanza has collaborated with various professionals in the field. Notable coworkers include John P Devlin and Robert Rothlein, who have contributed to his research and development efforts.
Conclusion
Genus J Possanza's work in the field of anti-inflammatory treatments showcases his dedication to improving patient outcomes. His innovative patents and collaborations highlight his significant role in advancing medical science.